These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 31160317)
21. Establishment and validation of the cut-off values of estimated glomerular filtration rate and urinary albumin-to-creatinine ratio for diabetic kidney disease: A multi-center, prospective cohort study. Gao Z; Zhu Y; Sun X; Zhu H; Jiang W; Sun M; Wang J; Liu L; Zheng H; Qin Y; Zhang S; Yang Y; Xu J; Yang J; Shan C; Chang B Front Endocrinol (Lausanne); 2022; 13():1064665. PubMed ID: 36578951 [TBL] [Abstract][Full Text] [Related]
22. Risk of cardiovascular disease, death, and renal progression in diabetes according to albuminuria and estimated glomerular filtration rate. Niu J; Zhang X; Li M; Wu S; Zheng R; Chen L; Huo Y; Xu M; Wang T; Zhao Z; Wang S; Lin H; Qin G; Yan L; Wan Q; Chen L; Shi L; Hu R; Tang X; Su Q; Yu X; Qin Y; Chen G; Gao Z; Wang G; Shen F; Luo Z; Chen Y; Zhang Y; Liu C; Wang Y; Wu S; Yang T; Li Q; Mu Y; Zhao J; Bi Y; Ning G; Wang W; Lu J; Xu Y; Diabetes Metab; 2023 Mar; 49(2):101420. PubMed ID: 36640827 [TBL] [Abstract][Full Text] [Related]
23. Diabetic kidney disease and risk of incident stroke among adults with type 2 diabetes. Kaze AD; Jaar BG; Fonarow GC; Echouffo-Tcheugui JB BMC Med; 2022 Mar; 20(1):127. PubMed ID: 35346165 [TBL] [Abstract][Full Text] [Related]
24. Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria: A CREDENCE Secondary Analysis. Jardine M; Zhou Z; Lambers Heerspink HJ; Hockham C; Li Q; Agarwal R; Bakris GL; Cannon CP; Charytan DM; Greene T; Levin A; Li JW; Neuen BL; Neal B; Oh R; Oshima M; Pollock C; Wheeler DC; de Zeeuw D; Zhang H; Zinman B; Mahaffey KW; Perkovic V Clin J Am Soc Nephrol; 2021 Mar; 16(3):384-395. PubMed ID: 33619120 [TBL] [Abstract][Full Text] [Related]
25. Changes in urinary albumin as a surrogate for kidney disease progression in people with type 2 diabetes. Yokoyama Y; Hanai K; Mori T; Yamamoto Y; Yoshida N; Murata H; Shinozaki T; Babazono T Clin Exp Nephrol; 2023 May; 27(5):465-472. PubMed ID: 36840900 [TBL] [Abstract][Full Text] [Related]
26. Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis. Agarwal R; Tu W; Farjat AE; Farag YMK; Toto R; Kaul S; Lawatscheck R; Rohwedder K; Ruilope LM; Rossing P; Pitt B; Filippatos G; Anker SD; Bakris GL; Ann Intern Med; 2023 Dec; 176(12):1606-1616. PubMed ID: 38048573 [TBL] [Abstract][Full Text] [Related]
27. Albuminuria and estimated glomerular filtration rate as predictors of diabetic end-stage renal disease and death. Berhane AM; Weil EJ; Knowler WC; Nelson RG; Hanson RL Clin J Am Soc Nephrol; 2011 Oct; 6(10):2444-51. PubMed ID: 21852671 [TBL] [Abstract][Full Text] [Related]
28. Comparison between urine albumin-to-creatinine ratio and urine protein dipstick testing for prevalence and ability to predict the risk for chronic kidney disease in the general population (Iwate-KENCO study): a prospective community-based cohort study. Koeda Y; Tanaka F; Segawa T; Ohta M; Ohsawa M; Tanno K; Makita S; Ishibashi Y; Itai K; Omama SI; Onoda T; Sakata K; Ogasawara K; Okayama A; Nakamura M BMC Nephrol; 2016 May; 17(1):46. PubMed ID: 27169575 [TBL] [Abstract][Full Text] [Related]
29. Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort. Dal Canto E; Elders PJM; van der Heijden AA; van Ballegooijen AJ; Lissenberg-Witte BI; Rutters F; Beulens JWJ Diabetologia; 2023 Mar; 66(3):482-494. PubMed ID: 36347992 [TBL] [Abstract][Full Text] [Related]
30. The prognosis of subjects showing a reduced estimated glomerular filtration rate without albuminuria in Japanese patients with type 2 diabetes: a cohort study for diabetic kidney disease. Ito H; Antoku S; Izutsu T; Kusano E; Matsumoto S; Yamasaki T; Mori T; Togane M Clin Exp Nephrol; 2020 Nov; 24(11):1033-1043. PubMed ID: 32734506 [TBL] [Abstract][Full Text] [Related]
31. Associations of Early Kidney Disease With Brain Magnetic Resonance Imaging and Cognitive Function in African Americans With Type 2 Diabetes Mellitus. Freedman BI; Sink KM; Hugenschmidt CE; Hughes TM; Williamson JD; Whitlow CT; Palmer ND; Miller ME; Lovato LC; Xu J; Smith SC; Launer LJ; Barzilay JI; Cohen RM; Sullivan MD; Bryan RN; Wagner BC; Bowden DW; Maldjian JA; Divers J; Am J Kidney Dis; 2017 Nov; 70(5):627-637. PubMed ID: 28648301 [TBL] [Abstract][Full Text] [Related]
32. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank. Jin Q; Luk AO; Lau ESH; Tam CHT; Ozaki R; Lim CKP; Wu H; Jiang G; Chow EYK; Ng JK; Kong APS; Fan B; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Huang Y; Lan HY; Szeto CC; So WY; Chan JCN; Ma RCW; Am J Kidney Dis; 2022 Aug; 80(2):196-206.e1. PubMed ID: 34999159 [TBL] [Abstract][Full Text] [Related]
33. Urine Albumin/Creatinine Ratio Below 30 mg/g is a Predictor of Incident Hypertension and Cardiovascular Mortality. Sung KC; Ryu S; Lee JY; Lee SH; Cheong E; Hyun YY; Lee KB; Kim H; Byrne CD J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27625343 [TBL] [Abstract][Full Text] [Related]
34. Cardiovascular and renal outcomes with varying degrees of kidney disease in high-risk people with type 2 diabetes: An epidemiological analysis of data from the AMPLITUDE-O trial. Gerstein HC; Mian R; Ramasundarahettige C; Branch KRH; Del Prato S; Lam CSP; Lopes RD; Pratley R; Rosenstock J; Sattar N Diabetes Obes Metab; 2024 Apr; 26(4):1216-1223. PubMed ID: 38116691 [TBL] [Abstract][Full Text] [Related]
35. Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease. Mann JFE; Fonseca V; Mosenzon O; Raz I; Goldman B; Idorn T; von Scholten BJ; Poulter NR Circulation; 2018 Dec; 138(25):2908-2918. PubMed ID: 30566006 [TBL] [Abstract][Full Text] [Related]
36. Reduction in albuminuria with dapagliflozin cannot be predicted by baseline clinical characteristics or changes in most other risk markers. Heerspink HJL; Sjöström CD; Inzucchi SE; Hallow MK; Cain VA; Rossing P; Stefansson BV; Sartipy P Diabetes Obes Metab; 2019 Mar; 21(3):720-725. PubMed ID: 30414240 [TBL] [Abstract][Full Text] [Related]
37. Prediction of kidney-related outcomes in patients with type 2 diabetes. Jardine MJ; Hata J; Woodward M; Perkovic V; Ninomiya T; Arima H; Zoungas S; Cass A; Patel A; Marre M; Mancia G; Mogensen CE; Poulter N; Chalmers J; Am J Kidney Dis; 2012 Nov; 60(5):770-8. PubMed ID: 22694950 [TBL] [Abstract][Full Text] [Related]
38. Effect of Vitamin D Supplementation on Kidney Function in Adults with Prediabetes: A Secondary Analysis of a Randomized Trial. Kim SH; Brodsky IG; Chatterjee R; Kashyap SR; Knowler WC; Liao E; Nelson J; Pratley R; Rasouli N; Vickery EM; Sarnak M; Pittas AG; ; Clin J Am Soc Nephrol; 2021 Aug; 16(8):1201-1209. PubMed ID: 34362787 [TBL] [Abstract][Full Text] [Related]
39. Association between 1-year changes in urinary albumin-to-creatinine ratio and kidney disease progression in Japanese individuals with diabetes: a historical cohort study. Babazono T; Hanai K; Yokoyama Y; Uchiyama K Clin Exp Nephrol; 2023 Dec; 27(12):1001-1009. PubMed ID: 37606804 [TBL] [Abstract][Full Text] [Related]
40. The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study. Oshima M; Jun M; Ohkuma T; Toyama T; Wada T; Cooper ME; Hadjadj S; Hamet P; Harrap S; Mancia G; Marre M; Williams B; Chalmers J; Woodward M; Perkovic V; Diabetologia; 2019 Nov; 62(11):1988-1997. PubMed ID: 31302707 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]